The US Food and Drug Administration (FDA) has hit Philips with a warning letter after quality control shortcomings were uncovered at three of its medical device manufacturing sites.

Gov. Tim Walz announced the audit on Wednesday, ordering payments for the 14 programs to halt for up to 90 days.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...